Track topics on Twitter Track topics that are important to you
As Sarepta Therapeutics waits for the FDA to announce an approval decision on a new drug to treat Duchenne muscular dystrophy, big questions hang over its top-selling medicine that's already on market. https://buff.ly/2Z7bpVh
Original Article: As Sarepta Therapeutics waits for the FDA to announce an approval decision on a new drug to treat Duchenne muscular dystrophy, big questions hang over its top-selling medicine that's already on market. https://buff.ly/2Z7bpVhNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...